November 3, 2024—Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the sa
QEII Conference Centre, London The British Society for Heart Failure’s Annual Meeting is the heart failure event of the year, bringing together 800 healthcare professionals…
Some doctors strive to remain apolitical with patients. In the most fractious election in US history, I’m moved to speak.
November 3, 2024—The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system (Ro
AIR-STEMI trial Update after FAVOR 3 trial publication
No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.
Preventive, Imaging, CardioOB Cardiologist & Scientist • Dad • Husband of a Stroke Survivor Hero • Emory Trained • #CardioObstetrics. 68 Followers.
Robotic-assisted aortic valve surgery may be a safe, effective alternative to TAVR when treating low- and intermediate-risk patients. A new analysis in The Annals of…
